My prescriber ordered three tests and this board recommends about twenty, and I would like to know which of those two lists is right.
What I actually want to know is what actually belongs on a baseline panel, as opposed to the enormous list that gets pasted around here.
Happy to be told the question itself is wrong.
Short answer first, then the reasoning. The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value. One out-of-range result in isolation generates anxiety and unnecessary tests; the same result next to the trend and the rest of the panel usually generates a shrug.
That is the short version; the long version is somebody else's post.
Dr.KarenChen said:The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value.
Agreed, and reference ranges are laboratory-specific. Comparing your number to somebody else's range, or to a screenshot from another country, is how people convince themselves something is wrong.
PeptideDetective — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsFitDadDave said:My prescriber ordered three tests and this board recommends about twenty, and I would like to know which of those two lists is right.
Same position here, arrived at the long way round. Quarterly for the first year is convention rather than evidence, and it is defensible for a simple reason: it is roughly the interval over which HbA1c becomes informative again, since it reflects about three months of glycaemia. After the first year, and once doses are stable, annual is reasonable unless something specific is being followed.
Adding the clinical framing, because it changes how the question reads.
Blood work came back perfect. baseline bloodwork + this community = winning. 🏆